Xsphera Biosciences
PrivateLast Round
Seed
Jun 15, 2022
Total Funding Raised
$481,800
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xsphera Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in June 2022.
Xsphera Biosciences is a biotechnology company that provides a fresh human tumor tissue-based platform for oncology therapeutic testing and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xsphera Biosciences Comparables
Compare Xsphera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitroScan | 89% | |
| Kiyatec | 88% | |
| Xilis | 87% |
For institutional investors. Book with your work email.
Xsphera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 15, 2022 | ||||
| Grant | Dec 12, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xsphera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Aquila Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 321% MoM, reaching 7.2K.
- Aug 20, 2026
Monthly visitors increased 46% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Xsphera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xsphera Biosciences's valuation, stock price, and market status.
Is Xsphera Biosciences a public or private company?
Xsphera Biosciences is a private company.
What is the current stock price of Xsphera Biosciences?
Xsphera Biosciences is a private company, so its shares have no public market price. Caplight tracks Xsphera Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xsphera Biosciences worth (valuation)?
Valuation information for Xsphera Biosciences is not publicly available.
Can I buy Xsphera Biosciences stock?
Xsphera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xsphera Biosciences's last funding round?
Xsphera Biosciences's most recent funding round was Seed on June 15, 2022.
Who are the main investors in Xsphera Biosciences?
Key investors in Xsphera Biosciences include U.S. Department of Health and Human Services, Aquila Capital Partners.
Will Xsphera Biosciences IPO soon?
No public IPO plans have been announced for Xsphera Biosciences.
How can I track Xsphera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Xsphera Biosciences's shares on secondary markets.